Clinical Trial Details

Trial ID: L0814
Source ID: KCT0002441
Associated Drug: Salsalate
Title: The comparison of effect between salsalate and placebo in osteoarthritis patients with nonalcoholic fatty liver disease: investigator initiated randomized placebo-controlled double-blind, pilot study.
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: ;Diseases of the musculo-skeletal system and connective tissue
Interventions: Drug : To compare those who took the salsalate (1 tablet = 500 mg) twice a day, 2 g (0 - 4 weeks), 3 g (4 - 8 weeks) with the placebo group in patients with osteoarthritis with nonalcoholic fatty liver
Outcome Measures: The change of hepatokines;The change of adipokinesThe change of hepatokines;The change of adipokines;The change of fatty liver and fibrosis index;The change of metabolic index;The change of liver function test and lipid profile;The change of inflammation mediators;The change of liver fibrosis factor;The change of symptoms and function of osteoarthritis;Safety (Side effect)
Sponsor/Collaborators: Koera University Guro Hospital
Gender: All
Age: 19(Year)No Limit
Phases: Not applicable
Enrollment: 34
Study Type: Interventional Study
Study Designs: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Start Date: 01/09/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 11 March 2019
Locations: Korea, Republic of
URL: http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=11346